2017 Tuberculosis Drug Discovery and Development Gordon Research Conference and Gordon Research Seminar

2017结核病药物发现与开发戈登研究大会暨戈登研究研讨会

基本信息

批准号：
9330545
负责人：
Courtney C Aldrich
金额：
$ 0.8万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-05-10 至 2018-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9330545
关键词：
Academia Anti-Bacterial Agents Applied Research Area Basic Science Biology Budgets Cessation of life Chemistry Clinical Drug Development Clinical Research Collaborations Communicable Diseases Communities Community Developments Development Disease Disease Resistance Drug Targeting Drug resistance Drug-sensitive Event Funding Funding Agency Health Priorities Human Individual Industry International Investments Italy Learning Medicine Metabolism Microbiology Multidrug-Resistant Tuberculosis Natural Products Participant Pharmacology Play Postdoctoral Fellow Prevention Renaissance Request for Applications Research Research Personnel Scientist Students Testing Training Tuberculosis United States National Institutes of Health Work design drug candidate drug development drug discovery experience global health graduate student improved meetings novel novel strategies novel therapeutics pre-clinical premature programs scaffold symposium tuberculosis drugs tuberculosis treatment

项目摘要

Project Abstract This application seeks partial support for the 2017 Tuberculosis (TB) Drug Discovery & Development Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) to be held in Lucca (Barga), Italy from June 24th-30th, 2017. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB Drug Discovery & Development is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 2017 GRC and GRS on TB Drug Discovery & Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture.

项目摘要本申请寻求对 2017 年结核病 (TB) 药物发现与开发 Gordon 的部分支持研究会议（GRC）和戈登研究研讨会（GRS）将于意大利卢卡（巴尔加）举行 2017 年 6 月 24 日至 30 日。这一两年一度的活动是研究人员齐聚一堂的最重要的全球会议学术界和工业界都在关注这个问题。结核病的治疗仍然是一个持续的挑战特别是随着耐药性问题的日益严重。新的治疗方法可以显着改善药物敏感和耐药疾病的治疗结果以及具有新作用模式的化合物为此正在积极寻求。结核病药物发现与开发是一个极其活跃的领域研究并越来越吸引具有不同背景的研究人员，包括微生物学、化学、药理学、医学和临床研究。 2017 年结核病药物研发 GRC 和 GRS 发展将为新研究人员提供了解该领域挑战的机会，并为经验丰富的研究人员在特别关键的时刻讨论最新的发现。